Home / Stock ratings / Robotics and Automation Stocks / OMCL

Stock rating

Omnicell Inc (OMCL) Stock Rating & Analysis

As of September 25, 2026, MELANY rates Omnicell Inc 60 out of 100 (Hold). Its highest factor score is earnings track record at 88, and its lowest is price momentum at 28.

MELANY ratingRated 2026-09-25

OMCL · composite score

60/100
Hold
···
Live price
Quality47
Momentum28
Risk-adjusted65
Source basis SEC filings and live market dataDated snapshot

Why OMCL scores 60/100

OMCL's 8 factor scores run from 28 to 88, and 4 of them sit above its composite of 60. Here is how OMCL breaks down.

Valuation55/100

Whether the price looks cheap or expensive against earnings, growth, and peers.

  • Forward P/E 16.1x, earnings growth accelerating
  • FCF yield 8.8%
Business quality47/100

Margins, returns on capital, and balance-sheet strength.

  • Gross margin 43%
Price momentum28/100

Direction and relative strength of the recent share-price trend.

Earnings track record88/100

History of beating or missing estimates, and where estimates are heading.

  • Avg EPS beat +29%
Analyst sentiment82/100

What Wall Street price targets and revisions are signalling.

  • Analyst targets 72% upside
  • Institutional net buying +3.2%
Catalyst setup72/100

Near-term events that could move the stock.

  • Earnings in 34 days
Risk-adjusted profile65/100

Upside weighed against volatility and drawdown risk.

Macro fit50/100

How the current rate and market regime suits this kind of company.

How OMCL compares

As of October 7, 2026, Omnicell Inc is tied for 10th of 17 in Robotics and Automation Stocks, where the average score is 61.

All stock rating pages.

Key risks for OMCL

  • Weak price momentum, trend not yet confirmed, may need more time to set up

Sector and theme context

Omnicell Inc sits in the Healthcare sector theme, which MELANY currently rates 44/100 for strength. Theme strength feeds OMCL's momentum and catalyst factors above.

Tracking OMCL

Omnicell Inc rates Hold right now, so MELANY is not flagging a fresh entry. Add OMCL to a watchlist in the app to follow its rating; an alert the moment it changes is part of Pro, free for 30 days.

How MELANY rates OMCL

MELANY is a rules-based engine that scores every stock from 0 to 100 across eight weighted factors, then re-scores as new price, earnings, and fundamental data arrive. Omnicell Inc's 60/100 reflects mature factor weighting for its profile.

Ratings are algorithmic and change with the data. They are research and education, not personalized investment advice.

Frequently asked questions about OMCL

Is Omnicell Inc (OMCL) a buy?

As of 2026-09-25, MELANY rated Omnicell Inc Hold with a composite score of 60/100. That is a dated snapshot, not the live rating, and it is an algorithmic reading built from eight factors rather than personalized investment advice. Review the factor breakdown above and the disclaimer below before making any decision.

What is Omnicell Inc's MELANY score?

Omnicell Inc (OMCL) has a MELANY composite score of 60/100, combining valuation, business quality, price momentum, earnings track record, analyst sentiment, catalyst setup, risk-adjusted profile, macro fit.

How is the OMCL stock rating calculated?

MELANY scores OMCL from 0 to 100 across eight weighted factors using live market and fundamental data, then refreshes the rating automatically as new data arrives.

Should I buy Omnicell Inc stock?

That decision is yours; Market Eyes Live does not give buy or sell advice. What the data says: MELANY rates Omnicell Inc (OMCL) Hold with a composite of 60/100 as of 2026-09-25. The factor breakdown above shows what is driving that, which is a better basis for a decision than any one-word verdict.

What is the OMCL stock price forecast?

MELANY does not publish price targets or forecasts for OMCL. Predicting a future price is exactly the kind of false precision the confidence framework avoids. Instead it scores today's setup, 60/100 across eight factors for Omnicell Inc, and re-scores automatically as new price, earnings, and fundamental data arrive.

Is OMCL stock overvalued or undervalued?

MELANY's valuation factor currently reads 55/100 for Omnicell Inc, where a higher score means the price looks more attractive on that measure. Scores in the 70s and above read as attractively priced, the mid range as roughly fair, and low scores as stretched. The factor breakdown above shows what drives OMCL's read.

What price should I buy OMCL at?

MELANY is not flagging a fresh entry for OMCL at its current Hold rating, so there is no entry zone to publish right now. Add OMCL to a watchlist in the app to follow it; an alert the moment the rating changes is part of Pro, free for 30 days.

What are the risks of buying OMCL stock?

The top risks MELANY currently flags for Omnicell Inc: Weak price momentum, trend not yet confirmed, may need more time to set up. The rating on this page already weighs these against the bullish factors; see the risk-adjusted profile score in the breakdown above.

Is Omnicell Inc a good long-term investment?

For long-term durability the two factors that matter most are business quality, which MELANY scores 47/100 for Omnicell Inc, and earnings track record, at 88/100. The 60/100 composite blends those with six shorter-horizon factors. Durable quality at a fair price is the long-term case to test; this is research, not personalized investment advice.

Will OMCL stock go up?

Nobody can promise a stock's direction, and Market Eyes Live does not predict prices. The measurable part: MELANY's price momentum factor reads 28/100 for OMCL right now, and the catalyst setup factor tracks whether near-term events could move it. Both re-score automatically as the data changes.

How current is this OMCL rating?

The rating on this page is a snapshot of MELANY's read as of 2026-09-25. The price shown updates live, but the score is not recomputed on this page. MELANY re-scores OMCL continuously as new price, earnings, and fundamental data arrive, and the current rating is in the app (Pro, free for 30 days).

How this rating works

Market Eyes Live

Every rating graded in public, OMCL included

MELANY scores more than 11,000 U.S. stocks and ETFs, PRISM ranks conviction and APEX writes the plan with one entry zone. Free to start on iOS and the web.

Get the free iOS app Create a free account on the web Free account, no card. Pro: 30 days free, then $9.99 a month.